ArticleThe Journal of clinical investigation2024

An in vivo screening platform identifies senolytic compounds that target p16INK4a+ fibroblasts in lung fibrosis.

Jin Young Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.